ADAM10

Disintegrin and metalloproteinase domain-containing protein 10 · O14672 · ADAM10 on Sugi Atlas →

12,126 patent compounds predicted against ADAM10, 9,288 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL206346 SCHEMBL206346 1.00 20/20
SCHEMBL207541 SCHEMBL207541 1.00 20/20
SCHEMBL207861 SCHEMBL207861 1.00 20/20
SCHEMBL209111 SCHEMBL209111 1.00 20/20
SCHEMBL1363578 SCHEMBL1363578 1.00 20/20
SCHEMBL1363704 SCHEMBL1363704 1.00 20/20
SCHEMBL1363723 SCHEMBL1363723 1.00 20/20
SCHEMBL1363898 SCHEMBL1363898 1.00 20/20
SCHEMBL1363900 SCHEMBL1363900 1.00 20/20
SCHEMBL1364081 SCHEMBL1364081 1.00 20/20
SCHEMBL1364108 SCHEMBL1364108 1.00 20/20
SCHEMBL1364132 SCHEMBL1364132 1.00 20/20
SCHEMBL1364161 SCHEMBL1364161 1.00 20/20
SCHEMBL1364254 SCHEMBL1364254 1.00 20/20
SCHEMBL1364266 SCHEMBL1364266 1.00 20/20
SCHEMBL1364342 SCHEMBL1364342 1.00 20/20
SCHEMBL1364417 SCHEMBL1364417 1.00 20/20
SCHEMBL1364431 SCHEMBL1364431 1.00 20/20
SCHEMBL1364454 SCHEMBL1364454 1.00 20/20
SCHEMBL1364544 SCHEMBL1364544 1.00 20/20

Clinical trials — most relevant to ADAM10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Estimation of MMP-8 Levels in GCF and Serum and Its Correlation With Wound Healing and Clinical Outcomes After Coronally Advanced Flap and Subepithelial Connective Tissue Graft for Root Coverage in Recession Defects: A CLINICO-BIOCHEMICAL STUDY PHASE4SUSPENDED
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. PHASE4COMPLETED
Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment PHASE3NOT_YET_RECRUITING
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery PHASE1/PHASE2UNKNOWN
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast PHASE2COMPLETED
The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement PHASE1COMPLETED
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer PHASE1COMPLETED
Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction nanCOMPLETED
Exercise and the Receptor for Advanced Glycation End Products (RAGE) nanCOMPLETED
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1 nanUNKNOWN
Evaluation of Different Serum Cartilage Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Subjects nanAVAILABLE
Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in Preeclampsia nanUNKNOWN
Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Apoptotic Changes in Gingiva Caused by Smoking nanCOMPLETED
Influence of Statins in Artery Aneurysms nanUNKNOWN
Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in Preeclampsia nanUNKNOWN
Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial nanCOMPLETED
Salivary Markers in Periodontal Disorders nanCOMPLETED
Peri-implantitis and MMP-8 nanCOMPLETED
Infection, Sepsis and Meningitis in Surinamese Neonates nanCOMPLETED
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma nanUNKNOWN
Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma nanCOMPLETED
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients nanCOMPLETED
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence nanWITHDRAWN
Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA nanUNKNOWN
The Biologic Basis of Hernia Formation nanCOMPLETED
Pathology, Venous Disease, and Clinical Correlations nanUNKNOWN
Impact of CASP3 Gene in Chemoresistance nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ADAM10 binder may also engage these)

ProteinNameSimilarity
O77633 1.000 O77633 →
Q10743 1.000 Q10743 →
Q10741 1.000 Q10741 →
O35598 1.000 O35598 →
Q8JIY1 1.000 Q8JIY1 →
Q9Z1K9 0.997 Q9Z1K9 →
Q9Z0F8 0.996 Q9Z0F8 →
Q9VAC5 0.994 Q9VAC5 →
G5EFD9 0.992 G5EFD9 →
G5ECS8 0.992 G5ECS8 →
Q19791 0.992 Q19791 →
Q9UKP5 0.992 Q9UKP5 →
O77636 0.991 O77636 →
ADAM17 Disintegrin and metalloproteinase domain-containing protein 17 0.991 landscape →
A4PBQ9 0.990 A4PBQ9 →
P59510 0.990 P59510 →
P86392 0.989 P86392 →
Q61YG1 0.989 Q61YG1 →
P11584 0.988 P11584 →
P12607 0.988 P12607 →
Q98SP2 0.988 Q98SP2 →
Q4VM08 0.988 Q4VM08 →
P0DM87 0.987 P0DM87 →
MMP14 Matrix metalloproteinase-14 0.987 landscape →
Q94316 0.987 Q94316 →
J9Z332 0.987 J9Z332 →
Q90YA6 0.987 Q90YA6 →
ITGB1 Integrin beta-1 0.987 landscape →
D4DCV9 0.987 D4DCV9 →
Q90495 0.987 Q90495 →